| Title | Pediatric Blood and Cancer |
| Abbreviation | Pediatr. Blood Cancer |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Hematology (Q1); Medicine (miscellaneous) (Q1); Pediatrics, Perinatology and Child Health (Q1); Oncology (Q2) |
| h-index | 133 |
| Overall Rank/Ranking | 4872 |
| SCImago Journal Rank (SJR) | 0.994 |
| Impact Score | 1.56 |
| Publisher | Wiley-Liss Inc. |
| Country | United States |
| ISSN | 15455017, 15455009 |
| Best Quartile | Q1 |
| Coverage History | 2004-2025 |
Pediatric Blood & Cancer will publish in print and online, the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood, including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.
Pediatric Blood and Cancer is a journal covering the technologies/fields/categories related to Hematology (Q1); Medicine (miscellaneous) (Q1); Pediatrics, Perinatology and Child Health (Q1); Oncology (Q2). It is published by Wiley-Liss Inc.. The overall rank of Pediatric Blood and Cancer is 4872. According to SCImago Journal Rank (SJR), this journal is ranked 0.994. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 133. The best quartile for this journal is Q1.
The ISSN of Pediatric Blood and Cancer journal is 15455017, 15455009. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Pediatric Blood and Cancer is cited by a total of 3624 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Pediatric Blood and Cancer is 1.56, which is computed in 2025 as per its definition. Pediatric Blood and Cancer IF is decreased by a factor of 0.32 and approximate percentage change is -17.02% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Pediatric Blood and Cancer is 1.56. If the same downward trend persists, Impact IF may fall in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.56 |
| 2023 | 1.88 |
| 2022 | 2.35 |
| 2021 | 2.66 |
| 2020 | 2.21 |
| 2019 | 2.10 |
| 2018 | 2.21 |
| 2017 | 2.50 |
| 2016 | 2.24 |
| 2015 | 2.72 |
| 2014 | 2.46 |
Pediatric Blood and Cancer has an h-index of 133. It means 133 articles of this journal have more than 133 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Pediatric Blood and Cancer is 15455017, 15455009. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Pediatric Blood and Cancer is 4872. According to SCImago Journal Rank (SJR), this journal is ranked 0.994. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.994 |
| 2023 | 0.992 |
| 2022 | 0.962 |
| 2021 | 1.009 |
| 2020 | 1.116 |
| 2019 | 1.143 |
| 2018 | 1.324 |
| 2017 | 1.338 |
| 2016 | 1.451 |
| 2015 | 1.480 |
| 2014 | 1.352 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 4872 |
| 2023 | 4509 |
| 2022 | 4489 |
| 2021 | 4053 |
| 2020 | 3706 |
| 2019 | 3512 |
| 2018 | 2800 |
| 2017 | 2792 |
| 2016 | 2502 |
| 2015 | 2435 |
| 2014 | 2725 |
Pediatric Blood and Cancer is published by Wiley-Liss Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 2004-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Pediatric Blood and Cancer is Pediatr. Blood Cancer. This abbreviation ('Pediatr. Blood Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Hematology (Q1); Medicine (miscellaneous) (Q1); Pediatrics, Perinatology and Child Health (Q1); Oncology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Pediatric Blood and Cancer latest impact IF is 1.56. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 2.72 (2015) and 1.56 (2024), respectively, in the last 11 years. Moreover, its average IS is 2.26 in the previous 11 years.
The Pediatric Blood and Cancer has an SJR (SCImago Journal Rank) of 0.994, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.480 in 2015 and the lowest being 0.962 in 2022. Furthermore, the average SJR of the Pediatric Blood and Cancer over the previous 11-year period stands at 2.26.
The latest h-index of the Pediatric Blood and Cancer is 133.
The Pediatric Blood and Cancer is published by the Wiley-Liss Inc., with its country of publication being the United States.
The Pediatric Blood and Cancer is currently ranked 4872 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 2435 in 2015 and its lowest position of 4872 in 2024.
The standard ISO4 abbreviation for the Pediatric Blood and Cancer is Pediatr. Blood Cancer.
Pediatric Blood and Cancer is classified as a journal that the Wiley-Liss Inc. publishes.
The Pediatric Blood and Cancer encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Pediatric Blood and Cancer is assigned the following International Standard Serial Numbers (ISSN): 15455017, 15455009.
The best quartile for the Pediatric Blood and Cancer is Q1 (2024).
The Pediatric Blood and Cancer coverage history can be summarized as follows: 2004-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Proceedings of the ASME Turbo Expo | conference and proceedings | 17577 | 54 | 0.00 | |
| Criminal Justice Review | journal | 10284 | SAGE Publications Inc. | 46 | 1.91 |
| Marine Biology Research | journal | 14618 | Taylor and Francis Ltd. | 47 | 1.21 |
| Syntax | journal | 2676 | Wiley-Blackwell Publishing Ltd | 35 | 1.10 |
| Transnational Corporations | journal | 13970 | UNCTAD United Nations Conference on Trade and Development | 30 | 1.63 |
| Studies in Continuing Education | journal | 4850 | Routledge | 44 | 3.35 |
| Palaeontographica Abteilung B: Palaeophytologie | book series | 10600 | Schweizerbart Science Publishers | 18 | 4.25 |
| Sapporo Medical Journal | journal | 29756 | Sapporo Medical University | 3 | 0.00 |
| Population Review | journal | 19550 | Sociological Demography Press | 15 | 0.59 |
| Epigenetics | journal | 4304 | Taylor and Francis Ltd. | 117 | 3.37 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.56 |
| 2023 | 1.88 |
| 2022 | 2.35 |
| 2021 | 2.66 |
| 2020 | 2.21 |
| 2019 | 2.10 |
| 2018 | 2.21 |
| 2017 | 2.50 |
| 2016 | 2.24 |
| 2015 | 2.72 |
| 2014 | 2.46 |
